Clinical trial
Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not…
NCT00121862 · Access to Advanced Health Institute (AAHI), Other · Completed
Key facts
| NCT number | NCT00121862 |
|---|---|
| Title | Study to Evaluate the Leish-111f + MPL-SE Vaccine in Healthy Adults Not Previously Exposed to Leishmania Parasite |
| Official title | A Study to Evaluate the Safety, Tolerability, and Immunogenicity of the Leish-111f + MPL-SE Vaccine Compared to the Leish-111f Protein Alone in Montenegro Skin Test-Negative Healthy Adults |
| Lead sponsor | Access to Advanced Health Institute (AAHI), Other |
| Collaborators | Bill and Melinda Gates Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cutaneous Leishmaniasis |
| Intervention type | Biological |
| Interventions | Leish-111f + MPL-SE vaccine |
| Enrollment | 60 |
| Start date | Aug 1, 2005 |
| Completion | Mar 1, 2006 |
| First posted | Jul 21, 2005 |
| Last update posted | May 5, 2006 |
| Countries | Colombia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: